150 related articles for article (PubMed ID: 32437964)
1. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.
Uccella S; Blank A; Maragliano R; Sessa F; Perren A; La Rosa S
Endocr Pathol; 2017 Dec; 28(4):351-361. PubMed ID: 29063495
[TBL] [Abstract][Full Text] [Related]
3. Proinsulin Expressing Neuroendocrine Tumors of the Pancreas: An Underrecognized Entity.
Celli R; Tang LH; Cai G; Freedman-Weiss M; Colunga M; Salem RR; Majumdar S; Jain D
Pancreas; 2019 Jan; 48(1):55-59. PubMed ID: 30451800
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and in situ hybridization analyses of glucose transporter 2 in pancreatic neuroendocrine tumors: Possible glucose transporter 2 association with neoplastic insulin production.
Watanabe H; Fujishima F; Unno M; Sasano H; Suzuki T
Pathol Res Pract; 2024 Jan; 253():154966. PubMed ID: 38043192
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
[TBL] [Abstract][Full Text] [Related]
6. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of proinsulin processing in functioning insulinomas: clinical implications.
Wiesli P; Perren A; Saremaslani P; Pfammatter T; Spinas GA; Schmid C
Clin Endocrinol (Oxf); 2004 Oct; 61(4):424-30. PubMed ID: 15473873
[TBL] [Abstract][Full Text] [Related]
8. Functioning human insulinomas. An immunohistochemical analysis of intracellular insulin processing.
Azzoni C; D'Adda T; Tamburrano G; Coscelli C; Madsen OD; Scopsi L; Bordi C
Virchows Arch; 1998 Dec; 433(6):495-504. PubMed ID: 9870681
[TBL] [Abstract][Full Text] [Related]
9. Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data.
Roth J; Komminoth P; Heitz PU
Am J Pathol; 1995 Aug; 147(2):489-502. PubMed ID: 7639339
[TBL] [Abstract][Full Text] [Related]
10. The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis.
Meng YF; Fan ZY; Yang J; Li YZ; Liu SJ; Gao CH; Gao X; Pang CY; Zhan HX
Front Endocrinol (Lausanne); 2023; 14():1137911. PubMed ID: 37033225
[TBL] [Abstract][Full Text] [Related]
11. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database.
Yang Z; Shi G
Eur J Surg Oncol; 2022 Oct; 48(10):2181-2187. PubMed ID: 35623986
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms.
Grolmusz VK; Kövesdi A; Borks K; Igaz P; Patócs A
Eur J Endocrinol; 2018 Oct; 179(4):219-228. PubMed ID: 30299890
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells.
Won JG; Tseng HS; Yang AH; Tang KT; Jap TS; Kwok CF; Lee CH; Lin HD
Metabolism; 2003 Oct; 52(10):1320-9. PubMed ID: 14564685
[TBL] [Abstract][Full Text] [Related]
14. Tumor and serum levels of proinsulin and insulin in insulinoma patients.
Tasaka Y; Nakaya F; Matsumoto H; Odagiri R; Ohgawara H; Omori Y
Endocr J; 1993 Apr; 40(2):245-8. PubMed ID: 7951510
[TBL] [Abstract][Full Text] [Related]
15. Sustained pulsatile insulin secretion from adenomatous human beta-cells. Synchronous cycling of insulin, C-peptide, and proinsulin.
Chou HF; Ipp E; Bowsher RR; Berman N; Ezrin C; Griffiths S
Diabetes; 1991 Nov; 40(11):1453-8. PubMed ID: 1936605
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
[TBL] [Abstract][Full Text] [Related]
17. Localization of proinsulin and insulin in human insulinoma: preliminary immunohistochemical results.
Roth J; Kasper M; Stamm B; Häcki WH; Storch MJ; Madsen OD; Klöppel G; Heitz PU
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):287-92. PubMed ID: 2565624
[TBL] [Abstract][Full Text] [Related]
18. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation.
de Vries C; Konukiewitz B; Weichert W; Klöppel G; Aupperle-Lellbach H; Steiger K
J Comp Pathol; 2020 Nov; 181():73-85. PubMed ID: 33288156
[TBL] [Abstract][Full Text] [Related]
19. Distribution patterns of proinsulin and insulin in human insulinomas: an immunohistochemical analysis in 76 tumors.
Roth J; Klöppel G; Madsen OD; Storch MJ; Heitz PU
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 63(1):51-61. PubMed ID: 1362022
[TBL] [Abstract][Full Text] [Related]
20. A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series.
Yu R; Nissen NN; Hendifar A; Tang L; Song YL; Chen YJ; Fan X
Pancreas; 2017 Jan; 46(1):48-56. PubMed ID: 27984486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
